Heart, Lung and Circulation
Brief Communication| Volume 19, ISSUE 2, P93-95, February 2010

Cardiac Isoform of Alpha 2 Macroglobulin and Its Reliability as a Cardiac Marker in HIV Patients


      Cardiac isoform of alpha 2 macroglobulin (CA2M), a serum protein (182000Mr) has been used as a diagnostic molecular marker for cardiac manifestations in HIV and diabetic patients. This study investigates the reliability of CA2M as an early diagnostic marker for cardiac manifestations in HIV patients and factors that could possibly influence their levels.


      A total of 206 serum samples were analysed from HIV patients with cardiac diseases (68), with non-cardiac ailments (48), opportunistic infections (34) and without other co-morbidities (56). The immuno-cross-reactivity between human serum CA2M and anti-rat CA2M antibody was tested and quantified by sandwich enzyme linked immunosorbent assay (ELISA).


      The CA2M levels were high in HIV patients with cardiac diseases irrespective of the manifestations. The CA2M levels were not influenced by opportunistic infections, non-cardiac ailments and patient parameters like age, sex, duration of illness, past history of other co-morbidities.


      CA2M can be used as a reliable early diagnostic marker in HIV patients with cardiac manifestations. CA2M levels were not influenced by other patient parameters.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Barbaro G.
        • Di Lorenzo G.
        • Grisorio B.
        Cardiac involvement in the acquired Immunodeficiency syndrome: a multicenter clinical–pathological study.
        AIDS Res Hum Retroviruses. 1998; 79: 599-604
        • Bozzette S.
        • Ake C.F.
        • Tam H.K.
        Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection.
        N Eng J Med. 2003; 348: 702-710
        • Lipshultz S.E.
        • Easley K.A.
        • Orav J.
        Left ventricular structure and function in children infected with human immunodeficiency virus: the Prospective P2C2 HIV Multicenter Study.
        Circulation. 1998; 97: 1246-1256
        • Hubbard J.
        Common biochemical markers for diagnosing heart disease.
        Nurs Times. 2003; 99: 24-25
        • Mariappan M.
        • Selvamurgan N.
        • Rajamanickam C.
        Purification and characterization of a high molecular weight protein induced in rat serum during the development of cardiac hypertrophy.
        Arch Biochem Biophys. 1994; 315: 558
        • Rathinavel A.
        • Dhandapani P.S.
        • Annapoorani P.
        • Ramasamy S.
        • Selvam G.S.
        Cardiac isoform of alpha-2 macroglobulin as a novel marker for cardiac diseases.
        Eur J Cardiovasc Prev Rehabil. 2005; 12: 601-603
        • Annapoorani P.
        • Dhandapany P.S.
        • Sadayappan S.
        • Ramasamy S.
        • Rathinavel A.
        • Selvam G.S.
        Cardiac isoform of alpha-2 macroglobulin—a new biomarker for myocardial infracted diabetic patients.
        Atherosclerosis. 2006; 186: 173-176
        • Ramasamy S.
        • Omnath R.
        • Rathinavel A.
        • Kannan P.
        • Dhandapany P.S.
        • Annapoorani P.
        • Balakumar P.
        • Singh M.
        • Ganesh R.
        • Selvam G.S.
        Cardiac isoform of alpha 2 macroglobulin, an early diagnostic marker for cardiac manifestations in AIDS patients.
        AIDS. 2006; 20: 1979-1981
        • Prabhakar R.
        • Rajamanickam C.
        Serum protein of 135-kDa molecular weight—a molecular signal for cardiac hypertrophy.
        Arch Biochem Biophys. 1993; 302: 425-430
        • Harlow E.
        • Lane D.P.
        Antibodies—a laboratory manual.
        Cold Spring Harbor Laboratory Press, 1988
        • Rajamanickam C.
        • Sakthivel S.
        • Kurian Joseph P.
        • Athimoolam Janarthanan R.
        A novel serum protein of molecular weight 182 kDa: a molecular marker for an early detection of increased left ventricular mass in patients with cardiac hypertrophy.
        J Cardiovasc Risk. 1998; 5: 335-338
        • Al-Attar I.
        • Orav E.J.
        • Vernat E.
        • Vlach S.A.
        • Lipshultz S.E.
        Predictors of cardiac morbidity and related mortality in children with acquired immunodeficiency syndrome.
        J Am Coll Cardiol. 2003; 41: 1598-1605
        • Barbaro G.
        Cardiovascular manifestations of HIV infection.
        J R Soc Med. 2001; 94: 384-390
        • Rajappa M.
        • Sharma A.
        Biomarkers of cardiac injury: an update.
        Angiology. 2005; 56: 677-691